Neurocrine Biosciences (NASDAQ:NBIX – Get Free Report) was downgraded by equities research analysts at StockNews.com from a “strong-buy” rating to a “buy” rating in a research note issued on Thursday.

Paulo Dybala is expected to undergo season-ending surgery next week.As reported by Il Messaggero, the Argentine will be ...

Investment analysts at William Blair increased their Q2 2025 EPS estimates for shares of Incyte in a research note issued on Tuesday, March 18th. William Blair analyst M. Phipps now expects that the ...

The best early Marvel Rival teams in North America are still battling it out for $100,000, and now it looks like the top dogs are separating themselves from tha ...

Migrants from Afghanistan, Russia, Iran and China deported from the United States and dropped into limbo in Panama hopped ...

This recipe comes to us from the blog, flowerpress. According to the blogger, to make Hugh Grant's favorite macaroni and ...

Britain’s Heathrow Airport has closed for the full day Friday after an electrical substation fire knocked out its power, ...

Justin Hancock, a horticulturist at Costa Farms, recommends the Thumbelina variety of carrots in particular, as it's an even ...

Anti-bribery and corruption agencies in the UK, France and Switzerland today announced a shared commitment to tackling international bribery ...

Here are some of the major stories about the Catholic Church from around the world that you may have missed this week: ...